| Bristol-Myers Squibb SA - Abraxane 250 mg, Pulver zur Herstellung einer Infusionssuspension |
| 63182 | | 02 | | Abraxane 250 mg | | Pulver zur Herstellung einer Infusionssuspension | | Codice | | | | 26.08.2014 | | |
|
| Composition |
| complexus paclitaxeli et albumini humani 300 mg et paclitaxelum 5 mg corresp. paclitaxelum 250 mg, albuminum humanum, pro vitro. |
| Packungsbestandteile |
| Pulver zur Herstellung einer Infusionssuspension | | | | | | Active Agent | Dose |
|---|
| Paclitaxel | 5 mg correspond Paclitaxel 250 mg |
| | | | Inactive agents | Dose |
|---|
| Albumini Humani | 300 mg | | Human Albumin | | | Complexus Paclitaxeli | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
